Digital X-Ray: Page 384

Fuji sparks PACS market with Synapse

By AuntMinnie.com staff writers

November 30, 1999

Agfa targets small hospitals with Impax Basix

By AuntMinnie.com staff writers

November 30, 1999

Lumisys shows upgrades to ACR 2000

By AuntMinnie.com staff writers

November 28, 1999

Risedronate reduces biochemical markers of cartilage degradation in knee osteoarthritis

NEW YORK (Reuters Health), Dec 19 - Pain is reduced and signs of disease modification are present when biochemical markers of cartilage degradation are used to assess knee osteoarthritis (OA). However, the bisphosphonate does not slow disease progression on radiography, investigators with the Knee Osteoarthritis Structural Arthritis (KOSTAR) study reported the November issue of Arthritis and Rheumatism.

December 31, 1998